Scarica l'app Stockscreener
12.94
1.25%
0.16
Dopo l'orario di chiusura:
13.00
0.06
+0.46%
Precedente Chiudi:
$12.78
Aprire:
$12.61
Volume 24 ore:
1.68M
Relative Volume:
1.43
Capitalizzazione di mercato:
$989.25M
Reddito:
$54.55M
Utile/perdita netta:
$-193.57M
Rapporto P/E:
-4.4775
EPS:
-2.89
Flusso di cassa netto:
$-181.86M
1 W Prestazione:
+16.68%
1M Prestazione:
+40.04%
6M Prestazione:
+12.23%
1 anno Prestazione:
-47.36%
Intervallo 1D:
$12.46
$13.19
Intervallo di 1 settimana:
$11.19
$13.23
Portata 52W:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Nome
Nurix Therapeutics Inc
Settore
Industria
Telefono
(415) 660-5320
Indirizzo
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Confronta NRIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
12.94 | 1.30B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Mizuho | Outperform |
| 2025-03-17 | Iniziato | Leerink Partners | Market Perform |
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | Jefferies | Buy |
| 2024-09-06 | Ripresa | Robert W. Baird | Outperform |
| 2024-07-31 | Iniziato | Truist | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-03-09 | Iniziato | Barclays | Overweight |
| 2023-02-28 | Iniziato | Oppenheimer | Outperform |
| 2022-10-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-12-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-04-30 | Ripresa | Piper Sandler | Overweight |
| 2021-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-04-14 | Iniziato | Berenberg | Buy |
| 2020-11-19 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-18 | Iniziato | Stifel | Buy |
Mostra tutto
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
Visual trend scoring systems applied to Nurix Therapeutics Inc.Weekly Risk Report & AI Forecast for Swing Trade Picks - newser.com
Can Nurix Therapeutics Inc. recover in the next quarterJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Full technical analysis of Nurix Therapeutics Inc. stockInsider Selling & Community Consensus Trade Alerts - newser.com
How institutional ownership impacts Nurix Therapeutics Inc. stock2025 Market WrapUp & Safe Entry Zone Tips - newser.com
How moving averages guide Nurix Therapeutics Inc. tradingDollar Strength & AI Enhanced Execution Alerts - newser.com
Is Nurix Therapeutics Inc. building a consolidation base2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com
Will Nurix Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com
Can Nurix Therapeutics Inc. stock hit record highs againTrade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
Nurix Therapeutics Inc. stock daily chart insights2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com
Will Nurix Therapeutics Inc. stock go up soonJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 3,130 Shares - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells $52,313.60 in Stock - MarketBeat
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies - MSN
Will Nurix Therapeutics Inc. bounce back from current supportPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock - Black Hills Pioneer
Applying chart zones and confluence areas to Nurix Therapeutics Inc.July 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
Nurix Therapeutics CFO van Houte sells $40k in shares By Investing.com - Investing.com UK
Nurix therapeutics CSO Hansen sells $52k in shares By Investing.com - Investing.com UK
Nurix Therapeutics, Inc. (NRIX) stock price, news, quote and history - Yahoo! Finance UK
Nurix Therapeutics CLO ring sells shares for $46,631 By Investing.com - Investing.com Canada
Needham Reiterates Nurix Therapeutics (NRIX) Buy Recommendation - MSN
Nurix Therapeutics CFO van Houte sells $40k in shares - Investing.com
Nurix therapeutics CSO Hansen sells $52k in shares - Investing.com
NRIX CFO files Form 4: RSU conversions and tax sell-to-cover - Stock Titan
Nurix insider reports RSU vesting and tax sell-to-cover - Stock Titan
NRIX insider updates: CSO holds 76,751 shares post transactions - Stock Titan
Nurix Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Nurix Therapeutics (Nasdaq: NRIX) to join Stifel Nov 13 and Jefferies Nov 19 webcasts - Stock Titan
HC Wainwright Cuts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $28.00 - MarketBeat
AlphaQuest LLC Boosts Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):